Home
Applications
Indications
Business
EpiSwitch
®
Products
EpiSwitch® COVID-19 Severity Test
EpiSwitch
®
Explorer Array Kit
EpiSwitch
®
Service
Investors
Investors Overview
Results and Presentations
Share Price Information
Regulatory News
Board & Governance
Key Corporate Documents
AIM Rule 26
Email Alerts
Investor Contacts
News
About Us
History
Board of Directors
Management Team
Scientific Advisory Panel
Values
Careers
Contact Us
Breast cancer: development of early non-invasive diagnostics to reduce disease mortality and psychological outcomes.
February 3, 2013
|
In
Episwitch Publication
|
By
oxfordbiodynamics
Psychoonkologia
, 2: 35–49, 2013
Prev
Next
Privacy Preference Center
Privacy Preferences
